Charles River Laboratories (CRL) — Financial Flexibility Index
Charles River Laboratories (CRL) has a Financial Flexibility Index of 0.04x as of June 2026. Free cash flow of $210.83 Million (operating CF $179.72 Million minus capex $31.11 Million) represents 0% of total liabilities ($4.69 Billion). Check CRL capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Charles River Laboratories Financial Flexibility Index (1998–2025)
Historical Financial Flexibility Index trend for Charles River Laboratories across 28 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Charles River Laboratories.
Annual Financial Flexibility Index for Charles River Laboratories (1998–2025)
Year-by-year free cash flow to debt coverage for Charles River Laboratories. Explore Charles River Laboratories debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.24x | $956.80 Million | $737.65 Million | $3.92 Billion | ▲ +1.3% |
| 2024 | 0.24x | $967.54 Million | $734.58 Million | $4.02 Billion | ▲ +8.9% |
| 2023 | 0.22x | $1.00 Billion | $683.90 Million | $4.54 Billion | ▲ +7.2% |
| 2022 | 0.21x | $944.37 Million | $619.64 Million | $4.58 Billion | ▼ -7.6% |
| 2021 | 0.22x | $989.57 Million | $760.80 Million | $4.43 Billion | ▲ +4.8% |
| 2020 | 0.21x | $713.13 Million | $546.58 Million | $3.35 Billion | ▲ +3.8% |
| 2019 | 0.21x | $621.45 Million | $480.94 Million | $3.03 Billion | ▼ -11.0% |
| 2018 | 0.23x | $581.19 Million | $441.14 Million | $2.52 Billion | ▲ +8.0% |
| 2017 | 0.21x | $398.70 Million | $316.26 Million | $1.87 Billion | ▲ +12.3% |
| 2016 | 0.19x | $353.61 Million | $298.32 Million | $1.86 Billion | ▼ -29.1% |
| 2015 | 0.27x | $349.61 Million | $286.36 Million | $1.30 Billion | ▲ +2.9% |
| 2014 | 0.26x | $307.98 Million | $251.05 Million | $1.18 Billion | ▲ +3.8% |
| 2013 | 0.25x | $246.29 Million | $207.14 Million | $979.96 Million | ▼ -3.3% |
| 2012 | 0.26x | $255.43 Million | $207.90 Million | $983.14 Million | ▲ +5.1% |
| 2011 | 0.25x | $254.43 Million | $205.28 Million | $1.03 Billion | ▲ +21.9% |
| 2010 | 0.20x | $211.87 Million | $169.01 Million | $1.04 Billion | ▼ -44.8% |
| 2009 | 0.37x | $305.06 Million | $225.04 Million | $830.27 Million | ▼ -26.0% |
| 2008 | 0.50x | $477.03 Million | $279.95 Million | $960.47 Million | ▼ -8.5% |
| 2007 | 0.54x | $511.28 Million | $284.25 Million | $941.57 Million | ▲ +49.5% |
| 2006 | 0.36x | $346.12 Million | $164.37 Million | $953.11 Million | ▼ -23.3% |
| 2005 | 0.47x | $332.25 Million | $236.70 Million | $701.48 Million | ▲ +135.5% |
| 2004 | 0.20x | $230.16 Million | $184.83 Million | $1.14 Billion | ▼ -58.3% |
| 2003 | 0.48x | $156.47 Million | $123.77 Million | $324.75 Million | ▼ -8.4% |
| 2002 | 0.53x | $171.20 Million | $133.66 Million | $325.40 Million | ▲ +31.0% |
| 2001 | 0.40x | $107.95 Million | $71.30 Million | $268.86 Million | ▲ +128.2% |
| 2000 | 0.18x | $49.33 Million | $33.77 Million | $280.35 Million | ▲ +64.7% |
| 1999 | 0.11x | $50.52 Million | $37.57 Million | $472.89 Million | ▼ -85.8% |
| 1998 | 0.75x | $49.29 Million | $37.38 Million | $65.69 Million | — |